Book a demo

Transform innovation
with AI agents

Patsnap connects the world’s largest proprietary innovation dataset with next-generation AI to accelerate R&D, IP, materials, and drug discovery. Innovate smarter, faster.

Get a demo

Trusted by 15,000 innovators worldwide

Make more time for energizing work with AI agents

Patsnap’s AI agents analyze billions of data points, surface key insights, and streamline decision-making. Give your R&D, IP, materials and life sciences teams a unique competitive advantage.

AI agents applied to innovation use cases

Enhancing human ingenuity

Use custom AI agents to eliminate tedious tasks and focus on what matters—researching,
experimenting, and winning in your market.

IP Agent

Novelty Search

Cut search time and boost productivity with fast, AI-driven prior art discovery.

R&D Agent

Technical Q&A

Receive precise and evidence-based technical answers, providing a one-stop solution for all R&D challenges.

Materials Agent

Material Scout

Finds materials that match your specified property ranges (e.g. tensile strength, thermal conductivity).

IP Agent

Patent Drafting

AI Analyzes Claims and Invention Disclosures to Generate High-Quality Patent Specifications.

LS Agent

Pharma Insights Advisor

Get drug discovery & development, competitive intelligence answers at your finger tips.

LS Agent

Markush Claim Drafting

Efficiently create Markush structure descriptions and claims for your novel compounds.

R&D Agent

Find Solutions

Leverage TRIZ and First Principles to generate high-quality technical solutions and inspire R&D creativity.

IP Agent

Design FTO Search

Conduct a FTO search for product appearance to avoid potential legal risks.

R&D Agent

Solution Feasibility Analysis

For technical solutions proposed by users, provide professional feasibility assessments and implementation recommendations.

Enterprise-grade security,
privacy, and compliance

Patsnap's LLM never trains on your data,
so your teams can innovate with confidence.

Learn more

Press

United AI Interview Series — Carl Rost, Principal Consultant at Patsnap

Patsnap Surpasses US$100 Million in Annual Recurring Revenue,
Reinforces Position as Global Leader in IP and R&D Intelligence

The Impact of AI on Patent Research and Analysis in Pharma